アテローム性動脈硬化症薬の世界市場 2021年:メーカー別、地域別、種類・用途別

【英語タイトル】Global Atherosclerosis Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが出版した調査資料(GIR21JY00001)・商品コード:GIR21JY00001
・発行会社(調査会社):GlobalInfoResearch
・発行日:2021年7月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2~3日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥396,720見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥595,080見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥793,440見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
GlobalInfoResearch社の本調査レポートでは、アテローム性動脈硬化症薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。アテローム性動脈硬化症薬の種類別市場規模(抗血小板薬、コレステロール低下薬、フィブリン酸・オメガ-3脂肪酸誘導体、その他)、用途別市場規模(小売薬局、病院薬局、オンライン薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):GlaxoSmithKline、Sanofi、F. Hoffmann-La Roche、Bayer、Novartis、Merck & Co、Janssen Pharmaceuticals、Mylan、Amgen Inc、Pfizer
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:抗血小板薬、コレステロール低下薬、フィブリン酸・オメガ-3脂肪酸誘導体、その他
・用途別分析2016年-2026年:小売薬局、病院薬局、オンライン薬局
・アテローム性動脈硬化症薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・アテローム性動脈硬化症薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・アテローム性動脈硬化症薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・アテローム性動脈硬化症薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・アテローム性動脈硬化症薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Atherosclerosis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Atherosclerosis Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Atherosclerosis Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Atherosclerosis Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Anti-platelet Medications
Cholesterol Lowering Medications
Fibric Acid and Omega-3 Fatty Acid Derivatives
Other

Market segment by Application, can be divided into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Market segment by players, this report covers
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche
Bayer
Novartis
Merck & Co
Janssen Pharmaceuticals
Mylan
Amgen Inc
Pfizer

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Atherosclerosis Drug
1.2 Classification of Atherosclerosis Drug by Type
1.2.1 Overview: Global Atherosclerosis Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Atherosclerosis Drug Revenue Market Share by Type in 2020
1.2.3 Anti-platelet Medications
1.2.4 Cholesterol Lowering Medications
1.2.5 Fibric Acid and Omega-3 Fatty Acid Derivatives
1.2.6 Other
1.3 Global Atherosclerosis Drug Market by Application
1.3.1 Overview: Global Atherosclerosis Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Atherosclerosis Drug Market Size & Forecast
1.5 Global Atherosclerosis Drug Market Size and Forecast by Region
1.5.1 Global Atherosclerosis Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Atherosclerosis Drug Market Size by Region, (2016-2021)
1.5.3 North America Atherosclerosis Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Atherosclerosis Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Atherosclerosis Drug Market Size and Prospect (2016-2026)
1.5.6 South America Atherosclerosis Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Atherosclerosis Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Atherosclerosis Drug Market Drivers
1.6.2 Atherosclerosis Drug Market Restraints
1.6.3 Atherosclerosis Drug Trends Analysis
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Atherosclerosis Drug Product and Solutions
2.1.4 GlaxoSmithKline Atherosclerosis Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GlaxoSmithKline Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Atherosclerosis Drug Product and Solutions
2.2.4 Sanofi Atherosclerosis Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche
2.3.1 F. Hoffmann-La Roche Details
2.3.2 F. Hoffmann-La Roche Major Business
2.3.3 F. Hoffmann-La Roche Atherosclerosis Drug Product and Solutions
2.3.4 F. Hoffmann-La Roche Atherosclerosis Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Atherosclerosis Drug Product and Solutions
2.4.4 Bayer Atherosclerosis Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bayer Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Atherosclerosis Drug Product and Solutions
2.5.4 Novartis Atherosclerosis Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Merck & Co
2.6.1 Merck & Co Details
2.6.2 Merck & Co Major Business
2.6.3 Merck & Co Atherosclerosis Drug Product and Solutions
2.6.4 Merck & Co Atherosclerosis Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Merck & Co Recent Developments and Future Plans
2.7 Janssen Pharmaceuticals
2.7.1 Janssen Pharmaceuticals Details
2.7.2 Janssen Pharmaceuticals Major Business
2.7.3 Janssen Pharmaceuticals Atherosclerosis Drug Product and Solutions
2.7.4 Janssen Pharmaceuticals Atherosclerosis Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Janssen Pharmaceuticals Recent Developments and Future Plans
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Atherosclerosis Drug Product and Solutions
2.8.4 Mylan Atherosclerosis Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Mylan Recent Developments and Future Plans
2.9 Amgen Inc
2.9.1 Amgen Inc Details
2.9.2 Amgen Inc Major Business
2.9.3 Amgen Inc Atherosclerosis Drug Product and Solutions
2.9.4 Amgen Inc Atherosclerosis Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Amgen Inc Recent Developments and Future Plans
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Atherosclerosis Drug Product and Solutions
2.10.4 Pfizer Atherosclerosis Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Pfizer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Atherosclerosis Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Atherosclerosis Drug Players Market Share
3.2.2 Top 10 Atherosclerosis Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Atherosclerosis Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Atherosclerosis Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Atherosclerosis Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Atherosclerosis Drug Revenue Market Share by Application (2016-2021)
5.2 Atherosclerosis Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Atherosclerosis Drug Revenue by Type (2016-2026)
6.2 North America Atherosclerosis Drug Revenue by Application (2016-2026)
6.3 North America Atherosclerosis Drug Market Size by Country
6.3.1 North America Atherosclerosis Drug Revenue by Country (2016-2026)
6.3.2 United States Atherosclerosis Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Atherosclerosis Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Atherosclerosis Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Atherosclerosis Drug Revenue by Type (2016-2026)
7.2 Europe Atherosclerosis Drug Revenue by Application (2016-2026)
7.3 Europe Atherosclerosis Drug Market Size by Country
7.3.1 Europe Atherosclerosis Drug Revenue by Country (2016-2026)
7.3.2 Germany Atherosclerosis Drug Market Size and Forecast (2016-2026)
7.3.3 France Atherosclerosis Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Atherosclerosis Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Atherosclerosis Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Atherosclerosis Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Atherosclerosis Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Atherosclerosis Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Atherosclerosis Drug Market Size by Region
8.3.1 Asia-Pacific Atherosclerosis Drug Revenue by Region (2016-2026)
8.3.2 China Atherosclerosis Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Atherosclerosis Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Atherosclerosis Drug Market Size and Forecast (2016-2026)
8.3.5 India Atherosclerosis Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Atherosclerosis Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Atherosclerosis Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Atherosclerosis Drug Revenue by Type (2016-2026)
9.2 South America Atherosclerosis Drug Revenue by Application (2016-2026)
9.3 South America Atherosclerosis Drug Market Size by Country
9.3.1 South America Atherosclerosis Drug Revenue by Country (2016-2026)
9.3.2 Brazil Atherosclerosis Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Atherosclerosis Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Atherosclerosis Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Atherosclerosis Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Atherosclerosis Drug Market Size by Country
10.3.1 Middle East & Africa Atherosclerosis Drug Revenue by Country (2016-2026)
10.3.2 Turkey Atherosclerosis Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Atherosclerosis Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Atherosclerosis Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Atherosclerosis Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Atherosclerosis Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Atherosclerosis Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Atherosclerosis Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Atherosclerosis Drug Revenue Market Share by Region (2021-2026)
Table 6. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 7. GlaxoSmithKline Major Business
Table 8. GlaxoSmithKline Atherosclerosis Drug Product and Solutions
Table 9. GlaxoSmithKline Atherosclerosis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Atherosclerosis Drug Product and Solutions
Table 13. Sanofi Atherosclerosis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 15. F. Hoffmann-La Roche Major Business
Table 16. F. Hoffmann-La Roche Atherosclerosis Drug Product and Solutions
Table 17. F. Hoffmann-La Roche Atherosclerosis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bayer Corporate Information, Head Office, and Major Competitors
Table 19. Bayer Major Business
Table 20. Bayer Atherosclerosis Drug Product and Solutions
Table 21. Bayer Atherosclerosis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Novartis Corporate Information, Head Office, and Major Competitors
Table 23. Novartis Major Business
Table 24. Novartis Atherosclerosis Drug Product and Solutions
Table 25. Novartis Atherosclerosis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Merck & Co Corporate Information, Head Office, and Major Competitors
Table 27. Merck & Co Major Business
Table 28. Merck & Co Atherosclerosis Drug Product and Solutions
Table 29. Merck & Co Atherosclerosis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Janssen Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. Janssen Pharmaceuticals Major Business
Table 32. Janssen Pharmaceuticals Atherosclerosis Drug Product and Solutions
Table 33. Janssen Pharmaceuticals Atherosclerosis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Mylan Corporate Information, Head Office, and Major Competitors
Table 35. Mylan Major Business
Table 36. Mylan Atherosclerosis Drug Product and Solutions
Table 37. Mylan Atherosclerosis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Amgen Inc Corporate Information, Head Office, and Major Competitors
Table 39. Amgen Inc Major Business
Table 40. Amgen Inc Atherosclerosis Drug Product and Solutions
Table 41. Amgen Inc Atherosclerosis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Pfizer Corporate Information, Head Office, and Major Competitors
Table 43. Pfizer Major Business
Table 44. Pfizer Atherosclerosis Drug Product and Solutions
Table 45. Pfizer Atherosclerosis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Atherosclerosis Drug Revenue (USD Million) by Players (2019-2021)
Table 47. Global Atherosclerosis Drug Revenue Share by Players (2019-2021)
Table 48. Breakdown of Atherosclerosis Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Atherosclerosis Drug Players Head Office, Products and Services Provided
Table 50. Atherosclerosis Drug Mergers & Acquisitions in the Past Five Years
Table 51. Atherosclerosis Drug New Entrants and Expansion Plans
Table 52. Global Atherosclerosis Drug Revenue (USD Million) by Type (2016-2021)
Table 53. Global Atherosclerosis Drug Revenue Share by Type (2016-2021)
Table 54. Global Atherosclerosis Drug Revenue Forecast by Type (2021-2026)
Table 55. Global Atherosclerosis Drug Revenue by Application (2016-2021)
Table 56. Global Atherosclerosis Drug Revenue Forecast by Application (2021-2026)
Table 57. North America Atherosclerosis Drug Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Atherosclerosis Drug Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Atherosclerosis Drug Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Atherosclerosis Drug Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Atherosclerosis Drug Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Atherosclerosis Drug Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Atherosclerosis Drug Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Atherosclerosis Drug Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Atherosclerosis Drug Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Atherosclerosis Drug Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Atherosclerosis Drug Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Atherosclerosis Drug Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Atherosclerosis Drug Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Atherosclerosis Drug Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Atherosclerosis Drug Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Atherosclerosis Drug Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Atherosclerosis Drug Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Atherosclerosis Drug Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Atherosclerosis Drug Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Atherosclerosis Drug Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Atherosclerosis Drug Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Atherosclerosis Drug Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Atherosclerosis Drug Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Atherosclerosis Drug Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Atherosclerosis Drug Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Atherosclerosis Drug Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Atherosclerosis Drug Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Atherosclerosis Drug Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Atherosclerosis Drug Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Atherosclerosis Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Atherosclerosis Drug Picture
Figure 2. Global Atherosclerosis Drug Revenue Market Share by Type in 2020
Figure 3. Anti-platelet Medications
Figure 4. Cholesterol Lowering Medications
Figure 5. Fibric Acid and Omega-3 Fatty Acid Derivatives
Figure 6. Other
Figure 7. Atherosclerosis Drug Revenue Market Share by Application in 2020
Figure 8. Retail Pharmacies Picture
Figure 9. Hospital Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Atherosclerosis Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Atherosclerosis Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Atherosclerosis Drug Revenue Market Share by Region (2016-2026)
Figure 14. Global Atherosclerosis Drug Revenue Market Share by Region in 2020
Figure 15. North America Atherosclerosis Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Atherosclerosis Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Atherosclerosis Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Atherosclerosis Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Atherosclerosis Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Atherosclerosis Drug Market Drivers
Figure 21. Atherosclerosis Drug Market Restraints
Figure 22. Atherosclerosis Drug Market Trends
Figure 23. GlaxoSmithKline Recent Developments and Future Plans
Figure 24. Sanofi Recent Developments and Future Plans
Figure 25. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 26. Bayer Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 28. Merck & Co Recent Developments and Future Plans
Figure 29. Janssen Pharmaceuticals Recent Developments and Future Plans
Figure 30. Mylan Recent Developments and Future Plans
Figure 31. Amgen Inc Recent Developments and Future Plans
Figure 32. Pfizer Recent Developments and Future Plans
Figure 33. Global Atherosclerosis Drug Revenue Share by Players in 2020
Figure 34. Atherosclerosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Atherosclerosis Drug Revenue Market Share in 2020
Figure 36. Global Top 10 Players Atherosclerosis Drug Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Atherosclerosis Drug Revenue Share by Type in 2020
Figure 39. Global Atherosclerosis Drug Market Share Forecast by Type (2021-2026)
Figure 40. Global Atherosclerosis Drug Revenue Share by Application in 2020
Figure 41. Global Atherosclerosis Drug Market Share Forecast by Application (2021-2026)
Figure 42. North America Atherosclerosis Drug Sales Market Share by Type (2016-2026)
Figure 43. North America Atherosclerosis Drug Sales Market Share by Application (2016-2026)
Figure 44. North America Atherosclerosis Drug Revenue Market Share by Country (2016-2026)
Figure 45. United States Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Atherosclerosis Drug Sales Market Share by Type (2016-2026)
Figure 49. Europe Atherosclerosis Drug Sales Market Share by Application (2016-2026)
Figure 50. Europe Atherosclerosis Drug Revenue Market Share by Country (2016-2026)
Figure 51. Germany Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Atherosclerosis Drug Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Atherosclerosis Drug Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Atherosclerosis Drug Revenue Market Share by Region (2016-2026)
Figure 59. China Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Atherosclerosis Drug Sales Market Share by Type (2016-2026)
Figure 66. South America Atherosclerosis Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Atherosclerosis Drug Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Atherosclerosis Drug Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Atherosclerosis Drug Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Atherosclerosis Drug Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Atherosclerosis Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source


【掲載企業】

GlaxoSmithKline、Sanofi、F. Hoffmann-La Roche、Bayer、Novartis、Merck & Co、Janssen Pharmaceuticals、Mylan、Amgen Inc、Pfizer

★調査レポート[アテローム性動脈硬化症薬の世界市場 2021年:メーカー別、地域別、種類・用途別] (コード:GIR21JY00001)販売に関する免責事項を必ずご確認ください。
★調査レポート[アテローム性動脈硬化症薬の世界市場 2021年:メーカー別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆